Congratulations to Erica E. Marsh, M.D., winner of the 2015 Ira and Ester Rosenwaks New Investigator Award.
Nominations are being sought for the 2016 Ira and Ester Rosenwaks New Investigator Award.
This award recognizes a member of the American Society for Reproductive Medicine who has made outstanding contributions to clinical or basic research in reproductive sciences published within ten (10) years after receiving a doctoral degree or completing residency/fellowship training. The recipient will have made original research contributions that significantly impact the field independently of his or her mentors. Other factors to be considered in making the award will include conceptual breakthrough, the significance of the research to allied fields of investigation, and development of new and innovative clinical or research methodologies.
Nominations may be submitted to Andrew R. La Barbera, Ph.D., ASRM Chief Scientific Officer, by members of the Society before June 1, 2016. Nominations must include a letter of nomination and the nominee’s curriculum vitae, bibliography and summary of research accomplishments in the field of reproductive medicine, and must be accompanied by letters of support from at least two additional senior members of the Society and/or scientific collaborators attesting to the originality and significance of the work. The recipient will be selected by the Executive Committee and notified by August 1, 2016. Previous nominees will be considered.
The recipient will be recognized as the Ira and Ester Rosenwaks New Investigator Awardee by presentation of a plaque at the ASRM 2016 Scientific Congress & Expo in Salt Lake City, Utah. In addition, the recipient will be provided with an honorarium of $1,000.00, free registration for the Scientific Congress in the year of the award, airfare/travel expenses up to $500, and up to $600 for two days hotel accommodations in the ASRM hotel room block, meals and ground transportation.
Previous recipients of the Ira and Ester Rosenwaks New Investigator Award:
- 2006 Anuja Dokras, M.D., Ph.D.
- 2007 Elizabeth A. McGee, M.D.
- 2008 William H. Catherino, M.D., Ph.D.
- 2009 Emre Seli, M.D.
- 2010 Ayman Al-Hendy, M.D., Ph.D.
- 2011 Lubna Pal, M.B.B.S., M.S.
- 2012 Clarisa R. Gracia, M.D., M.S.C.E.
- 2013 Nathan R. Treff, Ph.D.
- 2014 Jorge E. Chavarro, M.D., Sc.D.
- 2015 Erica E. Marsh, M.D.
Erica Elizabeth Marsh, M.D., has been selected as the 2015
recipient of the Ira and Ester Rosenwaks New Investigator Award. This award
recognizes a member of ASRM who has made outstanding contributions to clinical
or basic research in reproductive sciences published within 10 years after
completing research or clinical training and initiating an independent career
as an investigator.
|Dr. Marsh received her undergraduate and postgraduate medical education at Harvard Medical School and then pursued a fellowship in Reproductive Endocrinology an d Infertility at the Northwestern University Feinberg School of Medicine, where she has been Assistant Professor since 2008. She has published 27 peer-reviewed articles in excellent journals with 19 of them since completing his training. She has made significant original research contributions in the areas of uterine fibroids, endometriosis and female infertility. Her work has revealed the importance of specific miRNAs in fibroid biology especially in the excess production of disorganized extracellular matrix in this common neoplasm. She has recently focused on the role of obesity and metabolic dysregulation in the initiation and propagation of fibroid lesions. Of particular significance is Dr. Marsh’s work on the ethnic disparity of those suffering from uterine fibroids, a disease that is at least 3 times more common in women of color. Her unique combined community-basic science approach to study this phenomenon is really remarkable. It has already yielded important findings, such as the observation of higher aromatase expression in African American fibroid lesions, and is sure to produce many additional paradigm-shifting contributions to this important challenge in women health care.